551 related articles for article (PubMed ID: 27319211)
1. Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer.
Srivastava A; Babu A; Filant J; Moxley KM; Ruskin R; Dhanasekaran D; Sood AK; McMeekin S; Ramesh R
J Biomed Nanotechnol; 2016 Jun; 12(6):1159-73. PubMed ID: 27319211
[TBL] [Abstract][Full Text] [Related]
2. Exosomes as drug carriers for clinical application.
Di C; Zhang Q; Wang Y; Wang F; Chen Y; Gan L; Zhou R; Sun C; Li H; Zhang X; Yang H; Zhang H
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S564-S570. PubMed ID: 30431368
[TBL] [Abstract][Full Text] [Related]
3. Exosome mediated communication within the tumor microenvironment.
Milane L; Singh A; Mattheolabakis G; Suresh M; Amiji MM
J Control Release; 2015 Dec; 219():278-294. PubMed ID: 26143224
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.
Johnsen KB; Gudbergsson JM; Skov MN; Pilgaard L; Moos T; Duroux M
Biochim Biophys Acta; 2014 Aug; 1846(1):75-87. PubMed ID: 24747178
[TBL] [Abstract][Full Text] [Related]
5. Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy.
Wang X; Zhang H; Yang H; Bai M; Ning T; Li S; Li J; Deng T; Ying G; Ba Y
Curr Cancer Drug Targets; 2018; 18(4):347-354. PubMed ID: 28699500
[TBL] [Abstract][Full Text] [Related]
6. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
[TBL] [Abstract][Full Text] [Related]
7. Current Perspectives of Exosomes as Therapeutic Targets and Drug Delivery Vehicles for Pancreatic Cancer.
Srinivas L; S D; Kgk D; Malla RR
Crit Rev Oncog; 2019; 24(2):179-190. PubMed ID: 31679212
[TBL] [Abstract][Full Text] [Related]
8. From structures to functions: insights into exosomes as promising drug delivery vehicles.
Ren J; He W; Zheng L; Duan H
Biomater Sci; 2016 May; 4(6):910-21. PubMed ID: 26977477
[TBL] [Abstract][Full Text] [Related]
9. Engineering Exosomes for Cancer Therapy.
Gilligan KE; Dwyer RM
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28538671
[TBL] [Abstract][Full Text] [Related]
10. Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs.
Chinnappan M; Srivastava A; Amreddy N; Razaq M; Pareek V; Ahmed R; Mehta M; Peterson JE; Munshi A; Ramesh R
Cancer Lett; 2020 Aug; 486():18-28. PubMed ID: 32439419
[TBL] [Abstract][Full Text] [Related]
11. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications.
Mondal J; Pillarisetti S; Junnuthula V; Saha M; Hwang SR; Park IK; Lee YK
J Control Release; 2023 Jan; 353():1127-1149. PubMed ID: 36528193
[TBL] [Abstract][Full Text] [Related]
12. Emerging Significance and Therapeutic Potential of Extracellular vesicles.
Luo R; Liu M; Tan T; Yang Q; Wang Y; Men L; Zhao L; Zhang H; Wang S; Xie T; Tian Q
Int J Biol Sci; 2021; 17(10):2476-2486. PubMed ID: 34326688
[TBL] [Abstract][Full Text] [Related]
13. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
[TBL] [Abstract][Full Text] [Related]
14. Development and regulation of exosome-based therapy products.
Batrakova EV; Kim MS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):744-57. PubMed ID: 26888041
[TBL] [Abstract][Full Text] [Related]
15. Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application.
Yamashita T; Takahashi Y; Takakura Y
Biol Pharm Bull; 2018; 41(6):835-842. PubMed ID: 29863072
[TBL] [Abstract][Full Text] [Related]
16. Progress in the application of exosomes as therapeutic vectors in tumor-targeted therapy.
Xie X; Wu H; Li M; Chen X; Xu X; Ni W; Lu C; Ni R; Bao B; Xiao M
Cytotherapy; 2019 May; 21(5):509-524. PubMed ID: 30686589
[TBL] [Abstract][Full Text] [Related]
17. Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases.
Tran TH; Mattheolabakis G; Aldawsari H; Amiji M
Clin Immunol; 2015 Sep; 160(1):46-58. PubMed ID: 25842185
[TBL] [Abstract][Full Text] [Related]
18. Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy.
Zhan Q; Yi K; Qi H; Li S; Li X; Wang Q; Wang Y; Liu C; Qiu M; Yuan X; Zhao J; Hou X; Kang C
Theranostics; 2020; 10(17):7889-7905. PubMed ID: 32685027
[No Abstract] [Full Text] [Related]
19. Exosomes: Therapy delivery tools and biomarkers of diseases.
Barile L; Vassalli G
Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiological Role and Potential Therapeutic Exploitation of Exosomes in Ovarian Cancer.
Shimizu A; Sawada K; Kimura T
Cells; 2020 Mar; 9(4):. PubMed ID: 32230983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
